How should I manage a 29‑year‑old woman on combined oral contraceptives who has normal Pap and HPV results, a normal pelvic ultrasound, cervical ectropion with friability, two months of premenstrual cramping, and who declines STD testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management Approach

With normal Pap/HPV testing and normal pelvic ultrasound, the cervical ectropion with friability is most likely benign and related to her combined oral contraceptive use, requiring reassurance and symptomatic management of her premenstrual cramping rather than invasive intervention.

Cervical Findings Assessment

The cervical ectropion (columnar epithelium extending onto the ectocervix) with friability is a common benign finding in women using combined oral contraceptives. The hormonal effects of OCPs increase cervical ectropion, which can appear friable during examination. Since her Pap and HPV testing are both normal, there is no indication for colposcopy or further cervical evaluation 1.

Key Clinical Reasoning:

  • Normal Pap and HPV results effectively rule out cervical dysplasia or malignancy as causes of the friability
  • The presence of mucopurulent discharge or friability should not delay or invalidate Pap test results 1
  • Pap tests are satisfactory for evaluation even in the presence of cervical findings like ectropion 1

STD Testing Consideration

Despite declining STD testing, you should strongly counsel her about the importance of screening, particularly given the cervical friability. While she has the right to decline, explain that:

  • Cervical friability can be associated with cervicitis from Chlamydia trachomatis or Neisseria gonorrhoeae
  • The Pap test is not a screening test for STDs 1
  • Untreated STDs can lead to pelvic inflammatory disease and infertility

If she continues to decline, document this thoroughly in her chart. Consider offering self-collected vaginal swabs as an alternative if available, which may be more acceptable to some patients.

Management of Premenstrual Cramping

For her two months of significant premenstrual cramping, optimize her current OCP regimen or consider switching formulations. Combined oral contraceptives are effective for treating dysmenorrhea 2.

Treatment Algorithm:

  1. First-line approach - Continue current OCP but add NSAIDs (ibuprofen, naproxen, or mefenamic acid) for 5-7 days starting just before expected cramping 3, 2, 4

  2. If cramping persists after 3 months - Consider these options:

    • Switch to continuous or extended-cycle OCP regimen (skip placebo pills), which may reduce pain more effectively than standard 21/7 regimens 2
    • Change to a different OCP formulation with different progestin component 4
    • Increase estrogen content if she's on a very low-dose formulation 4
  3. Counseling points:

    • Reassure that cramping often improves after 3 months of consistent OCP use 4
    • NSAIDs are most effective when started before pain onset
    • Continuous OCP use may cause more irregular bleeding initially but reduces cramping 2

Cervical Ectropion Management

No treatment is needed for asymptomatic cervical ectropion. The friability noted during Pap collection does not require intervention when:

  • Pap and HPV are normal
  • No evidence of infection
  • Patient is asymptomatic between examinations

The ectropion may improve if she discontinues OCPs in the future, but this is not necessary given her normal screening results.

Follow-Up Plan

  • Cervical cancer screening: Resume at normal intervals for her age (typically every 3-5 years with co-testing) 1
  • Cramping reassessment: Follow up in 3 months to evaluate response to NSAIDs
  • STD screening: Offer again at next visit, emphasizing importance for reproductive health
  • Document: Her refusal of STD testing and your counseling about risks

Important Caveats

If any of the following develop, reevaluate immediately:

  • Postcoital bleeding
  • Intermenstrual bleeding that persists beyond 3 months on OCPs
  • Purulent cervical discharge
  • Pelvic pain beyond typical dysmenorrhea
  • Fever or signs of pelvic inflammatory disease

These would warrant STD testing regardless of patient preference, and potentially colposcopy if bleeding persists despite normal cytology 1.

The combination of normal screening tests, typical OCP-related cervical changes, and manageable dysmenorrhea indicates this patient needs supportive care and optimization of her current contraceptive method rather than invasive evaluation.

References

Guideline

sexually transmitted diseases treatment guidelines, 2010.

MMWR Recommendations and Reports, 2010

Research

Combined oral contraceptive pill for primary dysmenorrhoea.

The Cochrane database of systematic reviews, 2023

Guideline

u.s. selected practice recommendations for contraceptive use, 2024.

MMWR Recommendations and Reports, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.